Course Directors:
Vivian Weiss, MD, PhD
Paul VanderLaan, MD, PhD

Presenters:
Raul Gonzalez, MD
Tatsuki Koyama, PhD
Marcos Lepe, MD
Michiya Nishino, MD, PhD
Michael Thrall, MD
Paul VanderLaan, MD, PhD
Vivian Weiss, MD, PhD
Fei Ye, PhD, MSPH

DISCLOSURE OF RELEVANT FINANCIAL RELATIONSHIPS
The faculty, committee members, Executive Board and staff who are in position to control the content of this activity are required to disclose to the ASC and to learners any financial relationships that have occurred within the last 24 months with ineligible companies whose primary business is producing, marketing, selling, re-selling, or distributing healthcare products used by or on patients. The ASC has reviewed the disclosures and mitigated all relevant financial relationships.

The following individuals have reported financial relationships:
Oscar Lin, MD, PhD: Consultant – Hologic and Jansen
Liron Pantanowitz, MD: Consultant – Hamamatsu, Advisory Board for Ibex
Martha B Pitman, MD, FIAC: Consultant – Adenocyte, LLC
Donna K. Russell, MEd, CT(ASCP), HT(ASCP): Advisory Board – Hologic Scientific
Christopher J. VandenBussche, MD, PhD: Ad hoc advisory board panel and Consultant – Roche
Paul VanderLaan, MD, PhD: Consultant: Gala Therapeutics, Galvanize Therapeutics and Ruby Robotics

The following individuals have reported no relevant financial relationships:
Susan A. Alperstein, MS, CT(ASCP), Kristen A. Atkins, MD, Guliz A. Barkan, MD, Christine N. Booth, MD, Barbara A. Centeno, MD, Deborah J. Chute, MD, Amy C. Clayton, MD, Jacqueline M. Cuda, BS, SCT(ASCP), Kara L. Hansing, MEd, SCT(ASCP)CM, Sara E. Monaco, MD, Sinchita Roy-Chowdhuri, MD, PhD, Momin T. Siddiqui, MD, FIAC, Raul Gonzalez, MD, Tatsuki Koyama, PhD, Marcos Lepe, MD, Michiya Nishino, MD, PhD, Michael Thrall, MD, Vivian Weiss, MD, PhD and Fei Ye, PhD, MSPH

The ASC staff associated with the development of content for this activity reported no relevant financial relationships.